1. Baseline neutrophil-to-lymphocyte ratio and PD-L1 expression level or LDH value may predict outcome of patients with high PD-L1 advanced non-small cell lung cancer treated with first-line pembrolizumab. (January 2020) Authors: Banna, G.; Signorelli, D.; Metro, G.; Galetta, D.; De Toma, A.; Cantale, O.; Banini, M.; Friedlaender, A.; Pizzutillo, P.; Garassino, M.; Addeo, A. Journal: Lung cancer Issue: Volume 139(2020)Supplement 1 Page Start: S58 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Cancer and COVID-19: Unmasking their ties. (August 2020) Authors: Addeo, A.; Friedlaender, A. Journal: Cancer treatment reviews Issue: Volume 88(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. International survey of frailty assessment in patients with cancer. (December 2021) Authors: Banna, G.L.; Addeo, A.; Battisti, N.M.L.; Bambury, K.; Musolino, N.; O'Carroll, E.; Cantale, O.; Haydock, M.; Gomes, F. Journal: Journal of geriatric oncology Issue: Volume 12(2021)Supplement 1 Page Start: S67 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 38 Brain imaging before lung cancer resection? An analysis of data from Bristol. (January 2016) Authors: Hudson, Z.; Holdway, M.; Addeo, A. Journal: Lung cancer Issue: Volume 91(2016)Supplement 1 Page Start: S14 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗